Published in Diagnostics (Basel) on March 08, 2017
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13
Cancer statistics, 2016. CA Cancer J Clin (2016) 32.95
The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg (2009) 16.82
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet (2015) 7.50
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol (2010) 7.27
Ovarian cancer development and metastasis. Am J Pathol (2010) 5.92
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol (2007) 5.68
Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer (2007) 4.76
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol (2006) 3.96
Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol (2008) 3.68
Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol (2009) 3.59
Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst (2010) 3.42
The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol (2007) 3.02
Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin (2011) 2.57
Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol (2013) 2.39
Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study. J Natl Cancer Inst (2008) 2.34
Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol (2001) 2.12
A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer (2007) 2.07
Ovarian cancer in the United States: contemporary patterns of care associated with improved survival. Gynecol Oncol (2014) 1.86
Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography. Obstet Gynecol (2013) 1.77
Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol (2011) 1.72
BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype? Obstet Gynecol (2005) 1.63
The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol (2010) 1.61
The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy. Cancer (2009) 1.59
High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease. Gynecol Oncol (2013) 1.37
Tumors of the fimbriated end of the fallopian tube: a clinicopathologic analysis of 20 cases, including nine carcinomas. Int J Gynecol Pathol (1997) 1.23
The oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention". Clin Obstet Gynecol (2012) 1.13
Ovarian cancer screening. Clin Obstet Gynecol (2012) 1.05
Symptoms associated with ovarian cancer. Clin Obstet Gynecol (2012) 1.04
Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival. J Am Coll Surg (2015) 1.02
Early detection of ovarian tumors using ultrasound. Womens Health (Lond Engl) (2013) 0.90
Ovarian cancer screening: UKCTOCS trial - Authors' reply. Lancet (2016) 0.83
Screening women for ovarian cancer still does more harm than good. JAMA (2012) 0.82
Evaluation and Management of Ultrasonographically Detected Ovarian Tumors in Asymptomatic Women. Obstet Gynecol (2016) 0.80
Optimal primary therapy of ovarian cancer. Ann Oncol (2016) 0.80
Ovarian cancer screening effectiveness: A realization from the UK Collaborative Trial of Ovarian Cancer Screening. Womens Health (Lond Engl) (2016) 0.78
Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer. Eur J Surg Oncol (2015) 0.77